INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 425m ago
HOUSE PTR25m ago
SEC 13F25m ago
ROBINHOOD CHAIN25m ago
Public company

ORICOric Pharmaceuticals, Inc.

CIK 0001796280

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 5
Max Insider Score26
Connections2with evidence

ORIC · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$61K
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Piscitelli DominicChief Financial Officer · Aug 28, 2026
8
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL
$189K
14.0K sh
Oct 20, 2026
Oct 21, 2026
traded Oct 20, 2026
+1d
SEC FORM 4

Evidence

3
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

2
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$58K
13.4K sh
Sep 28, 2026Sep 29, 2026
traded Sep 28, 2026
+1dSEC FORM 4

Evidence

8
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$181K
13.4K sh
Sep 28, 2026Sep 29, 2026
traded Sep 28, 2026
+1dSEC FORM 4

Evidence

3
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
13.4K sh
Sep 28, 2026Sep 29, 2026
traded Sep 28, 2026
+1dSEC FORM 4

Evidence

0
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
600 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

0
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$2,616
600 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

1
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1,350
100 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

1
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$6,753
500 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

7
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
25.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

14
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$227K
52.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

10
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$150K
25.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

26
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1.05M
77.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

11
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
52.0K sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence